Insights On CONTRACT PHARMA MANUFACTURING

  1. Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV Production 5/19/2026

    Understanding how upstream control, downstream efficiency, and process robustness scale together is essential for protecting supply and expanding patient access.

  2. Built for Performance: High‑Quality Cartridge Production 5/19/2026

    A focused look at automated 3 mL cartridge processing, from washing and sterilization to monitored aseptic filling. Learn how precision filling, oRABS, and automation enable consistent, compliant production.

  3. AAV Upstream Process Development: High-Throughput To Clinical Scale 5/18/2026

    AAV manufacturing costs can exceed $1M per dose. See how DoE in a high-throughput system cut COGs by 60% and scaled AAV9 production to 2,000 L.

  4. AAV Capsid Analysis With Single Particle Mass Photometry 5/18/2026

    Accurate AAV capsid ratios are critical to gene therapy efficacy. See how mass photometry delivers faster, lower-cost E/F analysis with single-particle resolution.

  5. How To Advance Self-Administered Therapies 5/18/2026

    Scale your biologic fill-finish from vials to autoinjectors without disruption. See how integrated device assembly capabilities support every clinical phase through commercialization.

  6. Avoiding Regulatory Setbacks In OSD Development: Why Early Formulation Decisions Matter 5/18/2026

    Rushed OSD formulation decisions create costly downstream failures. Learn how strategic early-phase planning reduces CMC holds, scale-up risks, and regulatory delays.

  7. Evaluating The Entire Package System Under USP 382 5/18/2026

    USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.

  8. Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk 5/18/2026

    Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.

  9. How Peptides Became Cornerstones Of Modern Medicine 5/18/2026

    Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.

  10. A Rapid, Scalable Lentiviral Vector Purification Platform 5/15/2026

    Integrated capture and polishing reduce upstream impurities, enabling high‑capacity polishing, strong lentiviral recovery, and scalable purity for downstream in vivo applications.